Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-center study of bosentan in pediatric congenital heart disease-associated severe pulmonary arterial hypertension
ChiCTR-ONC-11001799Phase 4Completed
- Sponsor
- Beijing An Zhen Hospital
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bosentan in pulmonary arterial hypertension (PAH) and Cardiovascular Malformation (CVM), sponsored by Beijing An Zhen Hospital. Primary endpoint: Pulmonary vascular resistance. Started Dec 2010; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR-ONC-11001799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001799.